Biostax Corp (BTAX)

[TASBES0101]

Another thought I have is about the intellectual properties and market disrupting potential of LDN and DENK. It seems to me that IMUN would make a very attractive takeover target. Either by a big pharma company or an emerging markets player who can envision the potential. From what I've read there is huge potential. Heck, I'd like to try it myself! The studies and testimonials are really interesting. How well is the company insulated from a hostile takeover? Seems like it would be a possibility.

http://www.lowdosenaltrexone.org/